Advisor Group Holdings, Inc. Immunocore Holdings PLC Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,329 shares of IMCR stock, worth $39,936. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,329
Previous 1,377
3.49%
Holding current value
$39,936
Previous $42,000
7.14%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IMCR
# of Institutions
133Shares Held
41.2MCall Options Held
197KPut Options Held
424K-
Wellington Management Group LLP Boston, MA7.05MShares$212 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.5MShares$195 Million0.12% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$146 Million2.42% of portfolio
-
Primecap Management CO Pasadena, CA2.47MShares$74.3 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.16MShares$64.8 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.32B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...